5G4R

BROMODOMAIN OF HUMAN BRPF1 WITH N-1,3-dimethyl-6-2R-2- methylpiperazin-1-yl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl-2- methoxybenzamide

Summary for 5G4R

Entry DOI	10.2210/pdb5g4r/pdb
Related	5G4S
Descriptor	PEREGRIN, N-[1,3-dimethyl-6-[(2R)-2-methylpiperazin-1-yl]-2-oxidanylidene-benzimidazol-5-yl]-2-methoxy-benzamide (3 entities in total)
Functional Keywords	transcription
Biological source	HOMO SAPIENS (HUMAN)
Cellular location	Nucleus : P55201
Total number of polymer chains	4
Total formula weight	57341.60
Authors	Chung, C. (deposition date: 2016-05-16, release date: 2016-07-06, Last modification date: 2024-05-08)
Primary citation	Bamborough, P.,Barnett, H.A.,Becher, I.,Bird, M.J.,Chung, C.,Craggs, P.D.,Demont, E.H.,Diallo, H.,Fallon, D.J.,Gordon, L.J.,Grandi, P.,Hobbs, C.I.,Hooper-Greenhill, E.,Jones, E.J.,Law, R.P.,Le Gall, A.,Lugo, D.,Michon, A.,Mitchell, D.J.,Prinjha, R.K.,Sheppard, R.J.,Watson, A.J.B.,Watson, R.J. Gsk6853, a Chemical Probe for Inhibition of the Brpf1 Bromodomain. Acs Med.Chem.Lett., 7:552-, 2016 Cited by PubMed Abstract: The BRPF (Bromodomain and PHD Finger-containing) protein family are important scaffolding proteins for assembly of MYST histone acetyltransferase complexes. A selective benzimidazolone BRPF1 inhibitor showing micromolar activity in a cellular target engagement assay was recently described. Herein, we report the optimization of this series leading to the identification of a superior BRPF1 inhibitor suitable for in vivo studies. PubMed: 27326325 DOI: 10.1021/ACSMEDCHEMLETT.6B00092 PDB entries with the same primary citation
Experimental method	X-RAY DIFFRACTION (1.96 Å)

Structure validation